Clinical trial
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in…
NCT00097942 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00097942 |
|---|---|
| Title | Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients |
| Official title | A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients With Persistent Residual Symptoms |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | memantine HCl |
| Enrollment | 138 |
| Start date | Aug 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Dec 2, 2004 |
| Last update posted | Mar 5, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: